People: Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

67.50USD
4:03pm EDT
Change (% chg)

$0.02 (+0.03%)
Prev Close
$67.48
Open
$67.20
Day's High
$68.19
Day's Low
$67.01
Volume
1,795,818
Avg. Vol
1,815,967
52-wk High
$69.85
52-wk Low
$47.34

Search Stocks

Caforio, Giovanni 

Dr. Giovanni Caforio M.D., is Chief Executive Officer, Director of Bristol-Myers Squibb Company effective May 5, 2015. He has served as Chief Operating Officer, Director of the company effective May 5, 2015. He brings a broad range of experience to his role as chief operating officer. He joined Bristol-Myers Squibb in 2000 as vice president and general manager, Italy, and assumed leadership roles for Greece, South East Europe, and in 2004, was appointed senior vice president, European Marketing and Brand Commercialization. From 2007 to 2011, Caforio helped build the company’s leadership in immuno-oncology while directing U.S. and Global oncology, and made valuable contributions to the company’s strategic focus and operational performance in roles as U.S. president and chief commercial officer from 2011 to 2014. Prior to joining Bristol-Myers Squibb, Caforio spent 12 years with Abbott Laboratories in a number of leadership positions. Caforio earned his M.D. from the University of Rome prior to joining the pharmaceutical industry.

Basic Compensation

Total Annual Compensation, USD 3,041,000
Restricted Stock Awards, USD 3,999,630
Long-Term Incentive Plans, USD --
All Other, USD 204,543
Fiscal Year Total, USD 7,245,180

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Giovanni Caforio

7,245,180

Charles Bancroft

12,054,300

Louis Schmukler

--

Francis Cuss

7,078,980

Sandra Leung

8,054,800

Paul von Autenried

--
As Of  30 Dec 2014
Search Stocks